Pacmilimab Biosimilar – Anti-CD274, PD-L1, B7-H1 mAb – Research Grade

Size | |
---|---|
Brand | |
Product type | |
Clonality | |
Expression system | |
Applications |
Product name | Pacmilimab Biosimilar - Anti-CD274, PD-L1, B7-H1 mAb - Research Grade |
---|---|
Source | CAS 2145091-51-4 |
Species | Homo sapiens |
Expression system | Mammalian cells |
Purity | >85% |
Buffer | PBS buffer PH7.5 |
Delivery condition | Blue ice (+4°C) |
Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
Storage condition | store at -80°C |
Brand | ProteoGenix |
Applications | ELISA,WB |
Aliases /Synonyms | Pacmilimab ,CX-072,CD274, PD-L1, B7-H1,anti-CD274, PD-L1, B7-H1 |
Reference | PX-TA1600 |
Note | For research use only. Not suitable for clinical or therapeutic use. |
Isotype | IgG4-kappa |
Clonality | Monoclonal Antibody |
Pacmilimab Biosimilar - Anti-CD274, PD-L1, B7-H1 mAb binds to Human PDL1, B7-H1, CD274 recombinant protein in indirect ELISA Assay

Immobilized Human PDL1, B7-H1, CD274 recombinant protein (cat. No.PX-P4038) at 0.5µg/mL (100µL/well) can bind to Pacmilimab Biosimilar - Anti-CD274, PD-L1, B7-H1 mAb (cat. No.PX-TA1600) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450
Related products
Contact us
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.